ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "pregnancy"

  • Abstract Number: PP03 • ACR Convergence 2025

    My Journey of Risk, Loss, and Hope: The Role of Multidisciplinary Collaboration in Managing Pregnancy with Takayasu Arteritis

    Tugce Turten Kaymaz

    Background/Purpose: At the age of 26, the same month I got married, I was diagnosed with Takayasu Arteritis following severe chest and back pain. Hypertension…
  • Abstract Number: 2221 • ACR Convergence 2025

    Racial Differences in Cardiovascular Events and Adverse Pregnancy Outcomes Among Pregnant Individuals With Systemic Lupus Erythematosus

    Rashmi Dhital1, Rebecca Baer2 and Christina Chambers3, 1Vanderbilt University Medical Center, Brentwood, TN, 2University of California San Diego, San Diego, CA, 3University of California, San Diego, La Jolla, CA

    Background/Purpose: Pregnant individuals with systemic lupus erythematosus (SLE) face an increased risk of cardiovascular events (CVEs) as well as adverse pregnancy outcomes (APOs). While racial…
  • Abstract Number: 2200 • ACR Convergence 2025

    Obstetric and Neonatal Complications in Women living with Axial Spondyloarthritis: a population-based, matched cohort study

    Sinead Maguire1, John Snelgrove2, Priscila Pequeno3, Michael Paterson4, Fangyun Wu4, Laura Passalent5, Anthony Perruccio6, Dharini Mahendira7, Elie Karam8, Robert Inman9 and Nigil Haroon10, 1Our Lady's Hospital Navan, Dublin, Dublin, Ireland, 2Mount Sinai Hospital, Toronto, Canada, 3Institute for Clinical Evaluative Sciences (ICES), Toronto, Canada, 4Institute of Clinical & Evaluative Sciences, Toronto, Canada, 5Schroeder Arthritis Institute, University Health Network, Toronto, ON, Canada, 6Schroeder Arthritis Institute and Krembil Research Institute, University Health Network, Toronto, Canada, 7St Michael's Hospital, Toronto, Canada, 8Canadian Spondylitis Association, Toronto, Canada, 9University Health Network, Toronto, ON, Canada, 10Department of Medicine/Rheumatology, University Health Network, Schroeder Arthritis Institute, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Women with axial spondyloarthritis (axSpA) are frequently diagnosed during their childbearing years. While studies have reported on pregnancy complications in this population, deriving generalizable…
  • Abstract Number: 0853 • ACR Convergence 2025

    Olink Proteomics Identifies Macrophage Pro-inflammatory Proteins in Maternal Sera Predictive of Fetal Atrioventricular Block Independent of Maternal Health Status

    Philip Carlucci1, Mala Masson2, Colin Phoon3, Ashley Roman3, Peter Izmirly4, Amit Saxena5, Michael Belmont6, Christina Penfield3, Young Mi Lee3, Julie Nusbaum6, Andrew Rubenstein3, Nalani Sachan3, Joel Guthridge7, Judith James7, Elena Sinkovskaya8, Alfred Abuhamad8, Gary Satou9, Whitnee Hogan10, Anita Moon-Grady11, Lisa Howley12, Mary Donofrio13, Stephanie Levasseur14, Miwa Geiger15, Sonal Owens16, Kristopher Cumbermack17, Jyothi Matta18, Gary Joffe19, Christopher Lindblade20, Caitlin Haxel21, Katherine Kohari22, Joshua Copel22, James Strainic23, Tam Doan24, Conisha Holloman24, Stacy Killen25, Theresa Tacy26, Michelle Kaplinski26, Nicola Fraser3, Kelly Ruggles27, Bettina Cuneo28, Jill Buyon3 and Robert Clancy14, 1New York University School of Medicine, New York, NY, 2NYU Langone Medical Center- Division of Rheumatology, New York, NY, 3NYU Grossman School of Medicine, New York, NY, 4New York University Grossman School of Medicine, New York, NY, 5Division of Rheumatology, Department of Medicine, NYU Grossman School of Medicine, New York, NY, 6NYU Langone Health, New York, NY, 7Oklahoma Medical Research Foundation, Oklahoma City, OK, 8Eastern Virginia Medical School, Norfolk, VA, 9University of California Los Angeles, Los Angeles, CA, 10University of Utah, Salt Lake City, UT, 11University of California San Francisco, San Francisco, CA, 12Midwest Fetal Care Center, Children's Minnesota/Allina Health, Minneapolis, MN, 13Children's National Hospital, Washington, DC, 14Columbia University, New York, NY, 15Mount Sinai School of Medicine, New York, NY, 16University of Michigan, Ann Arbo, MI, 17University of Kentucky, Lexington, KY, 18University of Louisville, Louisville, KY, 19Perinatal Associates of New Mexico, Albuquerque, NM, 20Phoenix Children's Hospital, Phoenix, AZ, 21University of Vermont Children's Hospital, Burlington, VT, 22Yale University, New Haven, CT, 23UH Rainbow Babies, Cleveland, OH, 24Baylor College of Medicine, Houston, TX, 25Vanderbilt University, Nashville, TN, 26Stanford University, Stanford, CA, 27NYU Grossman School of Medicine, Brooklyn, NY, 28University of Arizona College of Medicine, Tucson, AZ

    Background/Purpose: Fetal atrioventricular block (fAVB) is presumed dependent on the transplacental passage of SSA/Ro52/60kD autoantibodies that bind to apoptotic fetal cardiomyocytes, triggering macrophage activation and…
  • Abstract Number: 2655 • ACR Convergence 2025

    Fetal and maternal outcomes in systemic sclerosis and very early diagnosis of systemic sclerosis pregnancies, a national prospective study

    Anne Murarasu1, lauren beaudeau2, Véronique Le Guern3, gaelle guettrot-Imbert3, claire cazalets4, cecile durant5, Cecile Yelnik6, Céline Roussin7, Marie-Charlotte Besse8, Emilie Berthoux9, Emmanuel Chatelus10, Eric Hachulla11, Estibaliz LAZARO12, Francois Maurier13, Gaelle leroux14, Grégory Pugnet15, Isabelle durieu16, Loic RAFFRAY17, Maelle Le Besnerais18, Mélanie roriz19, Odile SOUCHAUD-DEBOUVERIE20, Patrick JEGO21, Pauline ORQUEVAUX22, Claire de Moreuil23, Helene MAILLARD24, Nathalie Morel25, Anna Molto26, Camille Le Ray27, emmanuelle pannier27, loic sentilhes25, Luc Mouthon28, Nathalie Costedoat-Chalumeau29 and Benjamin Chaigne30, 1Tours University Hospital, Tours, France, 2Centre Hospitalier Ales Les Cevennes, Ales, France, 3Cochin hospital, Paris, France, 4Rennes Hospital, Rennes, France, 5Nantes University Hospital, Nantes, France, 6lille university, Lille, France, 7Centre Hospitalier Ouest Réunion, Saint Paul, France, 8Tours University Hospital, 37000 tours, Ile-de-France, France, 9Internal Medicine, Saint Luc Saint Joseph Hospital, Lyon, France, 10Department of Rheumatology, University Hospital Strasbourg, France, Strasbourg, France, 11University of Lille, LILLE, France, 12Bordeaux University Hospital, Pessac, France, 13HOPITAUX PRIVES DE METZ, Vaux / Frankreich, France, 14Pitié-Salpêtrière University Hospital, Paris, France, 15CHU Toulouse Rangueil Service de Medecine Interne et Immunologie Clinique, Toulouse, France, 16Lyon University Hospital, Lyon, France, 17Félix-Guyon University Hospital of La Réunion, Saint Denis, France, 18Rouen University Hospital, Rouen, France, 19Agen hospital, Agen, France, 20Poitiers University Hospital, Poitiers, France, 21Rennes University Hospital, Rennes, France, 22Reims University Hospital, Reims, France, 23CHU DE BREST, BREST, France, 24Lille University Hospital, Lille, France, 25Bordeaux University Hospital, Bordeaux, France, 26Assistance Publique Hôpitauxde Paris, Paris, France, 27Cochin Port Royal University Hospital, Paris, France, 28Hopital Cochin - Paris University, Paris, France, 29Inserm DR Paris 5, Paris, France, 30Cochin University Hospital, Paris, France

    Background/Purpose: Pregnancy in women with systemic sclerosis (SSc) is considered high-risk due to complications like scleroderma renal crisis and preeclampsia, related to vasculopathy. Prospective data…
  • Abstract Number: 2219 • ACR Convergence 2025

    Transcriptomic and Immune Landscape of Recurrent Pregnancy Loss and Unexplained Infertility in Systemic Lupus Erythematosus

    Rodolfo Martinez-Canales1, Braulio R. Avalos-Garcia2, Andres M. Ortiz-Rios2, Eva Abigaid Galindo-Calvillo2, Lorena Perez-Barbosa2, Dionicio A. Galarza-Delgado3, Cassandra Michele Skinner-Taylor2, Mario Cesar Salinas-Carmona1 and Noe Macias-Segura1, 1Immunology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Nuevo Leon, Mexico, 2Rheumatology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Nuevo Leon, Mexico, 3Rheumatology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico

    Background/Purpose: Recurrent pregnancy loss (RPL) and unexplained infertility (UIF) are significant reproductive health challenges in patients with systemic lupus erythematosus (SLE). SLE causes systemic inflammation…
  • Abstract Number: 2199 • ACR Convergence 2025

    Disparities in Reproductive Health Counseling Among Hispanic Women with Autoimmune Rheumatic Diseases: Insights from a Patient-Reported Survey in an Urban Safety-Net Setting

    Eaman Alhassan1, Laura Kobashigawa2, Vanessa Ramos2, Jack Rodman2 and Leanna Wise3, 1University of Pittsburgh Medical Center, Pittsburgh, PA, 2University of Southern California, Los Angeles, 3LAGMC/Keck Medicine of USC, Los Angeles

    Background/Purpose: Reproductive-age Hispanic women with rheumatoid arthritis, juvenile idiopathic arthritis (combined, inflammatory arthritis; IA), and systemic lupus erythematosus (SLE) often bear a higher disease burden…
  • Abstract Number: 0794 • ACR Convergence 2025

    Using Artificial Intelligence to Analyze Multilingual Qualitative Data in Lupus Pregnancy Research: A Proof of Concept with Large Language Models

    Romina Boers1, Grace Terry2 and Bella Mehta3, 1Weil Cornell Medicine, New York, 2Weil Cornell Medicine, Ne wYork, 3Hospital for Special Surgery, Weill Cornell Medicine, Jersey City, NJ

    Background/Purpose: Women with systemic lupus erythematosus (SLE), particularly those of childbearing age, face heightened risks during pregnancy, including disease flares, adverse maternal-fetal outcomes, and emotional…
  • Abstract Number: 2632 • ACR Convergence 2025

    Maternal vascular malperfusion: association with adverse perinatal outcomes in lupus pregnancies

    ANA JIMENA LOPEZ DIAZ1, MARIA DEL CARMEN ZAMORA MEDINA2, Mario Isaac Lumbreras Márquez1, Diana Yazmin Copado mendoza1, Oralia Alejandra Orozco Guillén1, Maria José rodríguez Sibaja1, Martha Leticia Palafox Vargas1 and Sandra Acevedo gallegos1, 1Instituto Nacional de Perinatología, Mexico City, Distrito Federal, Mexico, 2Instituto Nacional de Perinatologia, Mexico City, Distrito Federal, Mexico

    Background/Purpose: Systemic lupus erythematosus (SLE) is associated with increased risk of adverse perinatal outcomes (APOs), including preeclampsia, preterm birth, fetal growth restriction, and stillbirth. Placental…
  • Abstract Number: 2218 • ACR Convergence 2025

    Pregnancy Outcomes and Placental Findings in Women with IgA Vasculitis: A Case-Control Study

    Edgar Iván Mendoza Ríos, María Del Carmen Zamora Medina, Mario Isaac Lumbreras Márquez, Diana Yazmin Copado mendoza, Oralia Alejandra Orozco Guillén, Maria José rodríguez Sibaja, Martha Leticia Palafox Vargas and Sandra Acevedo gallegos, Instituto Nacional de Perinatología, Mexico City, Distrito Federal, Mexico

    Background/Purpose: IgA vasculitis (IgA-V) is a systemic vasculitis involving small vessels, most frequently affecting children. There is few information about pregnancy outcomes in women with…
  • Abstract Number: 2198 • ACR Convergence 2025

    Sociocultural Influences on Pregnancy Planning for Individuals Diagnosed with SLE in an Urban Hispanic Population: A Qualitative Study with Considerations for a Holistic Approach

    Andrew Ramirez1, Alexa Montes de Oca1, Martha Delgado1, Mellissa withers1 and Leanna Wise2, 1University of Southern California, Los Angeles, 2LAGMC/Keck Medicine of USC, Los Angeles

    Background/Purpose: As systemic lupus erythematosus (SLE) often affects women of child-bearing age, understanding how this population makes reproductive health decisions is critical for well-rounded healthcare.…
  • Abstract Number: 0213 • ACR Convergence 2025

    Development of a Predictive Tool for Obstetric Risk Stratification in Autoimmune Rheumatic Diseases: A Meta-Analysis-Based Model

    Noe Macias-Segura1, Rodolfo Martinez-Canales1, Braulio R. Avalos-Garcia2, Andres M. Ortiz-Rios2, Eva Abigaid Galindo-Calvillo2, Mario Cesar Salinas-Carmona1, Lorena Perez-Barbosa2, Dionicio A. Galarza-Delgado3 and Cassandra Michele Skinner-Taylor2, 1Immunology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Nuevo Leon, Mexico, 2Rheumatology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Nuevo Leon, Mexico, 3Rheumatology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico

    Background/Purpose: Autoimmune rheumatic diseases (ARDs) such as systemic lupus erythematosus (SLE), antiphospholipid syndrome (APS), rheumatoid arthritis (RA), and Sjögren's syndrome significantly increase the risk of…
  • Abstract Number: 2631 • ACR Convergence 2025

    Dapirolizumab Pegol, a Novel CD40L Inhibitor, Showed No Adverse Outcomes in an In Vivo Non-Human Primate Reprotoxicity Study and Displayed Minimal to No Human Placental Transfer in an Ex Vivo Study

    Lewis Renshall1, Birgit Hirschmugl2, Bernd Potthoff3, Emmanuel Goursaud3, Pierre Bonnaillie3, Sarah Kettell3, Veerle Snoeck3, Emma Smith4, Farnaz Fallah-Arani4, Anthony Shock4, Alison Wolfreys4, Christian Wadsack2 and Paul Brownbill1, 1Maternal and Fetal Health Research Centre, University of Manchester, Manchester, United Kingdom, 2Department of Obstetrics and Gynecology, Medical University of Graz, Graz, Austria, 3UCB, Braine-l’Alleud, Belgium, 4UCB, Slough, United Kingdom

    Background/Purpose: Dapirolizumab pegol (DZP) is a novel CD40L inhibitor with broad modulatory effects on SLE immunopathology;1,2 it consists of a polyethylene glycol (PEG)-conjugated antigen-binding fragment…
  • Abstract Number: 2216 • ACR Convergence 2025

    Expanding Reproductive Health Assessments in Rheumatic Diseases: A Comparative Analysis of Demographic and Disease-Specific Factors

    Krista Topalsky1, Chelsea Guan2, Lindsay Frumker3, Dana Nachawati2, Areeb Tiwana4, Meghan Gump2, Omer Pamuk5 and Marina Magrey6, 1University Hospitals, Shaker Heights, OH, 2University Hospitals Cleveland Medical Center/Case Western Reserve University, Cleveland, OH, 3University hospitals Cleveland medical center, Highland Heights, OH, 4Canton Medical Education Foundation, Canton, OH, 5University Hospitals Cleveland Medical Center/ Case Western Reserve University, Cleveland, OH, 6Case Western Reserve University School of Medicine/University Hospitals Cleveland, Richfield, OH

    Background/Purpose: Building on our 2024 ACR study (Topalsky et al.) that described broad knowledge gaps and interest in reproductive health education among women with rheumatic…
  • Abstract Number: 2197 • ACR Convergence 2025

    Mechanisms of Fetal Growth Restriction in Rheumatologic Autoimmune Diseases: Insights into Placental Pathology and Immune Dysregulation

    Larabe Farrukh1, Ananya Venkatesh2, Mana Parast2 and Chelsey Smith3, 1University of California San Diego, San Diego, CA, 2University of California San Diego, San Diego, 3University of California San Diego, LA JOLLA, CA

    Background/Purpose: Fetal growth restriction (FGR) significantly contributes to adverse pregnancy outcomes (APOs) in women with rheumatologic diseases. Understanding the immunopathologic mechanisms underlying FGR is critical…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 22
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology